Almarys is a long‑term play

Grounded in lasting value and future potential

Lorem Ipsum lorem Lorem

Almarys is listed on the Official Market of the Stock Exchange of Mauritius. The company holds 13,300 arpents of strategically located agricultural land and a 25.38% equity stake in Société Helicophanta. Through investment in Almarys, shareholders access a strategic minority stake in a world-class biotech company offering both recurring cash flows and medium-term growth potential.

Almarys offers a blend of asset-backed security and innovative growth opportunities to its shareholders.

Annual report
2021

Annual report 2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Investor corner

3 good reasons to invest in Almarys

Strong asset base
Shareholders will own a company with significant land holdings.

Stable recurring revenue
Consistent cash flows from Société Helicophanta and the rental of land.

Long-term growth potential
Appreciation potential of land holdings; strategic entry into the emerging biotechnology sector.

Thank you for your interest.

We have registered your subscription for our e‑communications.

Thank you for your interest.

We have registered your subscription to our investor alerts.

Thank you for your interest.

We have received your message and will
get back to you shortly.